Hypertoniebehandlung bei Nierenarterienstenose [Hypertension therapy in patients with renal artery stenosis].

Détails

ID Serval
serval:BIB_E5DF3D4282AE
Type
Article: article d'un périodique ou d'un magazine.
Sous-type
Synthèse (review): revue aussi complète que possible des connaissances sur un sujet, rédigée à partir de l'analyse exhaustive des travaux publiés.
Collection
Publications
Institution
Titre
Hypertoniebehandlung bei Nierenarterienstenose [Hypertension therapy in patients with renal artery stenosis].
Périodique
Therapeutische Umschau. Revue Thérapeutique
Auteur⸱e⸱s
Vogt B., Maillard M., Burnier M.
ISSN
0040-5930 (Print)
ISSN-L
0040-5930
Statut éditorial
Publié
Date de publication
05/2012
Volume
69
Numéro
5
Pages
279-281
Langue
allemand
Notes
Publication types: English Abstract ; Journal Article ; ReviewPublication Status: ppublish
Résumé
Renovascular hypertension is due to reduced renal parenchymal perfusion. The correct diagnosis can be difficult. It is important to note that the demonstration of renal artery stenosis in a patient with hypertension does not necessarily constitute renovascular hypertension. Often, clinically nonsignificant and asymptomatic renal artery stenosis are found in patients with essential hypertension, or renal failure of other origin. Renovascular disease is a complex disorder with various clinical presentations. In patients with significant renovascular hypertension plasma renin is increased. For this reason the therapy aims to block the renin-angiotensin-aldosterone system. Bilateral renal artery stenosis causes renal sodium retention. In this situation a diuretic drug has to be added to the therapy. Endovascular or surgical therapy has to be considered in patients with flash pulmonary edema or fibromuscular dysplasia. The control of cardiovascular risk factors is important.
Mots-clé
Antihypertensive Agents/adverse effects, Antihypertensive Agents/therapeutic use, Blood Pressure/drug effects, Diuretics/therapeutic use, Glomerular Filtration Rate/drug effects, Humans, Hypertension, Renovascular/drug therapy, Kidney/blood supply, Renal Artery Obstruction/drug therapy, Renin/blood, Renin-Angiotensin System/drug effects, Risk Factors
Pubmed
Création de la notice
24/07/2012 14:44
Dernière modification de la notice
20/08/2019 16:09
Données d'usage